Relafen 750, chemically known as naproxol, exemplifies a fascinating case study from a biochemical medicinal viewpoint. Its mechanism of reducing inflammation involves the targeted inhibition of cyclooxygenase-2 (COX-2), an enzyme vital for the creation of prostanoids, potent agents of inflammation and pain. Unlike older NSAIDs, Relafen 750's chara